NCT04158791View on ClinicalTrials.gov

Outcomes Based on the Pre-operative Integrity of IS/OS Junction in Idiopathic Epimacular Membrane Surgery

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

March 25, 2018

Primary Completion Date

February 15, 2019

Study Completion Date

July 9, 2019

Conditions
Epimacular Membrane
Interventions
PROCEDURE

pars plana vitrectomy with epimacular membrane removal and internal limiting membrane peeling

25-gauge pars plana vitrectomy with a solution of 0.15% trypan blue, 0.025% brilliant blue G, 4% polyethylene glycol (MembraneBlue Dual) assisted ERM/ILM removal performed by a single surgeon (GV); no air-fluid exchange was performed during surgery. In phakic eyes, phacoemulsification with intraocular lens implantation was performed at the time of vitrectomy.

Trial Locations (1)

20133

Carlo Bruttini, Milan

All Listed Sponsors
lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER

NCT04158791 - Outcomes Based on the Pre-operative Integrity of IS/OS Junction in Idiopathic Epimacular Membrane Surgery | Biotech Hunter | Biotech Hunter